Diphenylpyraline
From Wikipedia, the free encyclopedia
Diphenylpyraline
|
|
Systematic (IUPAC) name | |
4-benzhydryloxy-1-methyl-piperidine | |
Identifiers | |
CAS number | |
ATC code | R06 |
PubChem | |
DrugBank | |
Chemical data | |
Formula | C19H23NO |
Mol. mass | 281.392 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Diphenylpyraline is an antihistamine.
[edit] External links
- Lapa G, Mathews T, Harp J, Budygin E, Jones S (2005). "Diphenylpyraline, a histamine H1 receptor antagonist, has psychostimulant properties". Eur J Pharmacol 506 (3): 237–40. doi: . PMID 15627433.
- Ohno T, Kobayashi S, Hayashi M, Sakurai M, Kanazawa I (2001). "Diphenylpyraline-responsive parkinsonism in cerebrotendinous xanthomatosis: long-term follow up of three patients". J Neurol Sci 182 (2): 95–7. doi: . PMID 11137513.
- Puhakka H, Rantanen T, Virolainen E (1977). "Diphenylpyraline (Lergobine) in the treatment of patients suffering from allergic and vasomotor rhinitis". J Int Med Res 5 (1): 37–41. PMID 14039.
|